✦ LIBER ✦

Epidermal growth factor receptor (EGFR)-inhibitors, rashes, and survival: Is doxycycline the missing link?

✍ Scribed by David Palma

Book ID: 113833312
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 107 KB
Volume: 46
Category: Article
ISSN: 1368-8375
DOI: 10.1016/j.oraloncology.2010.02.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

How important is the pus culture obtaine

How important is the pus culture obtained from epithelial growth factor receptor (EGFR) inhibitors’ associated rash?

✍ Evangelos Cholongitas; George Kokolakis; Despina Ioannidou 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB

930 THE EPIDERMAL GROWTH FACTOR RECEPTOR

930 THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) IS FREQUENTLY OVEREXPRESSED IN PENILE SQUAMOUS CARCINOMAS

✍ Netto, George; Cubilla, Antonio L.; Sharma, Rajni; Lecksell, Kristen; Katz, Beti 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 46 KB

The tumor-specific de2–7 epidermal growt

The tumor-specific de2–7 epidermal growth factor receptor (EGFR) promotes cells survival and heterodimerizes with the wild-type EGFR

✍ Luwor, Rodney B; Zhu, Hong-Jian; Walker, Francesca; Vitali, Angela A; Perera, Ru 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 275 KB

Mutations in the epidermal growth factor

Mutations in the epidermal growth factor receptor gene and effects of EGFR-tyrosine kinase inhibitors on lung cancers

✍ Takayuki Fukui; Tetsuya Mitsudomi 📂 Article 📅 2008 🏛 Springer Japan 🌐 Japanese ⚖ 265 KB

6-Substituted-4-(3-bromophenylamino)quin

6-Substituted-4-(3-bromophenylamino)quinazolines as Putative Irreversible Inhibitors of the Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor (HER-2) Tyrosine Kinases with Enhanced Antitumor Activity

✍ Tsou, Hwei-Ru; Mamuya, Nellie; Johnson, Bernard D.; Reich, Marvin F.; Gruber, Br 📂 Article 📅 2001 🏛 American Chemical Society 🌐 English ⚖ 252 KB

Prophylactic tetracycline does not dimin

Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB)

✍ Aminah Jatoi; Shaker R. Dakhil; Jeff A. Sloan; John W. Kugler; Kendrith M. Rowla 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 257 KB